Dimensional Fund Advisors
LUMO

Dimensional Fund Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Dimensional Fund Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,278
Closed -$97.8K – 3379
2024
Q3 		$97.8K Sell
25,278
-4,309
-15% -$11.9K ﹤0.01% 3240
2024
Q2 		$68.6K Sell
29,587
-30
-0.1% -$77 ﹤0.01% 3287
2024
Q1 		$83.5K Buy
29,617
+14,053
+90% +$41.6K ﹤0.01% 3279
2023
Q4 		$48.7K Hold
15,564
– – ﹤0.01% 3347
2023
Q3 		$51.4K Sell
15,564
-4,525
-23% -$14.1K ﹤0.01% 3379
2023
Q2 		$66.3K Hold
20,089
– – ﹤0.01% 3382
2023
Q1 		$68.1K Sell
20,089
-642
-3% -$2.25K ﹤0.01% 3356
2022
Q4 		$75 Hold
20,731
– – ﹤0.01% 3360
2022
Q3 		$184K Hold
20,731
– – ﹤0.01% 3256
2022
Q2 		$160K Hold
20,731
– – ﹤0.01% 3276
2022
Q1 		$196K Hold
20,731
– – ﹤0.01% 3318
2021
Q4 		$144K Sell
20,731
-222
-1% -$1.86K ﹤0.01% 3393
2021
Q3 		$199K Sell
20,953
-18,452
-47% -$173K ﹤0.01% 3349
2021
Q2 		$392K Sell
39,405
-2,054
-5% -$22.9K ﹤0.01% 3212
2021
Q1 		$485K Sell
41,459
-2,089
-5% -$35.1K ﹤0.01% 3146
2020
Q4 		$1.55M Sell
43,548
-215
-0.5% -$3.71K ﹤0.01% 2877
2020
Q3 		$605K Buy
43,763
+2,668
+6% +$39.9K ﹤0.01% 3023
2020
Q2 		$678K Buy
41,095
+6,596
+19% +$78.5K ﹤0.01% 3020
2020
Q1 		$293K Buy
34,499
+5,347
+18% +$74.7K ﹤0.01% 3153
2019
Q4 		$664K Sell
29,152
-5,964
-17% -$85.1K ﹤0.01% 3091
2019
Q3 		$503K Hold
35,116
– – ﹤0.01% 3136
2019
Q2 		$468K Hold
35,116
– – ﹤0.01% 3198
2019
Q1 		$610K Sell
35,116
-6,647
-16% -$99.1K ﹤0.01% 3130
2018
Q4 		$571K Buy
41,763
+9,948
+31% +$175K ﹤0.01% 3126
2018
Q3 		$684K Buy
31,815
+25,836
+432% +$786K ﹤0.01% 3131
2018
Q2 		$256K Hold
5,979
– – ﹤0.01% 3216
2018
Q1 		$390K Hold
5,979
– – ﹤0.01% 3142
2017
Q4 		$436K Sell
5,979
-2,698
-31% -$223K ﹤0.01% 3113
2017
Q3 		$795K Sell
8,677
-4,742
-35% -$364K ﹤0.01% 3033
2017
Q2 		$888K Buy
13,419
+3,848
+40% +$476K ﹤0.01% 2998
2017
Q1 		$2.08M Buy
9,571
+2,462
+35% +$352K ﹤0.01% 2831
2016
Q4 		$658K Buy
7,109
+2,361
+50% +$266K ﹤0.01% 3049
2016
Q3 		$642K Sell
4,748
-328
-6% -$32.6K ﹤0.01% 3021
2016
Q2 		$514K Sell
5,076
-238
-4% -$29.5K ﹤0.01% 3044
2016
Q1 		$870K Sell
5,314
-76
-1% -$15.4K ﹤0.01% 2944
2015
Q4 		$1.76M Buy
5,390
+34
+0.6% +$11.1K ﹤0.01% 2841
2015
Q3 		$1.73M Buy
5,356
+55
+1% +$24.2K ﹤0.01% 2860
2015
Q2 		$2.11M Buy
+5,301
New +$2.25M ﹤0.01% 2846

Dimensional Fund Advisors's LUMO Position: Q4 2024 in Review

Dimensional Fund Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 25,278 shares — an estimated $97.8K sold.

Dimensional Fund Advisors first reported a position in LUMO in Q2 2015 and held it in 38 quarters. The position peaked at $2.11M in Q2 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Dimensional Fund Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 25,278 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $97.8K.
  • Dimensional Fund Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 38 quarters.
  • Dimensional Fund Advisors's Lumos Pharma, Inc. Common Stock position peaked at $2.11M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.